Prediction of Surgical Treatment Effect by Preoperative Imaging:Present and Future Perspectives

Abstract

Get full access to this article

View all access options for this article.

References

1. Maes A , Flameng W , Nuyts J , Borgers M , et al: Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 90:735-745, 1994.

2. Vanoverschelde J-LJ , Wijns W , Depre C , Essamri B , et al: Mechanisms of chronic regional postischemic dysfunction in humans: New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 87:1513-1523, 1993.

3. Rahimtoola SH : The hibernating myocardium. Am Heart J 117:211-221, 1989.

4. Bolli R : Myocardial “stunning” in man. Circulation 86:1671-1691, 1992.

5. Marshall RC , Tillisch JH , Phelps ME , Huang SC , et al: Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 67:766-778, 1983.

6. Bax JJ , Cornel JH , Visser FC , Fioretti RM , et al: Accuracy of currently available techniques to predict functional recovery after revascularization in patients with chronic left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol 30:1451-1460, 1997.

7. Dilsizian V , Rocco TR , Freedman NM , Leon MB , et al: Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 323:141-146, 1990.

8. Dilsizian V , Perrone-Filardi P , Arrighi JA , Bacharach SL , et al: Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission topography. Circulation 88:941-952, 1993.

9. Galassi AR , Centamore G , Fiscella A , Coppola A , et al: Comparison of rest-redistribution thallium-201 imaging and reinjection after stress-redistribution for the assessment of myocardial viability in patients with left ventricular dysfunction secondary to coronary artery disease. Am J Cardiol 75:436-442, 1995.

10.

10. Beanlands RS , Dawood F , Wen WH , McLaughlin PR , et al: Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 82:1802-1814, 1990.

11.

11. Freeman L , Grunwald AM , Hoory S , Bodenheimer MM : Effect of coronary occlusion and myocardial viability on myocardial activity of technetium-99m-sestamibi [see comments]. J Nucl Med 32:292-298, 1991.

12.

12. Cigarroa CG , deFilippi CR , Brickner ME , Alvarez LG , et al: Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 88:430-436, 1953.

13.

13. Eitzman D , al-Aouar Z , Kanter HL , vom DJ , KirshM , et al: Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 20:559-565, 1992.

14.

14. Kaul S : There may be more to myocardial viability than meets the eye. Circulation 92:2790-2793, 1995.

15.

15. Marwick TH , Nemec JJ , Lafont A , Salcedo EE , et al: Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am J Cardiol 69:854-859, 1992.

16.

16. DiCarli M , Asgarzadie F , Schelbed HR , Bnunken RC , et al: Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 92:3436-3444, 1995.

17.

17. Bax JJ , Patton JA , Poldermans D , Elhendy A , et al: 18Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: Cardiac applications. Semin Nucl Med 30:281-288, 2000.

18.

18. Pigott JD , Kouchoukos N , Oberman A , Cutter GR : Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol 5:1036-1045, 1985.

19.

19. Bax JJ , Wijns W : FDG imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging? J Nucl Med 40:1893-1895, 1999.

20.

20. Gioia G , Milan E , Giubbini R , DePace N , et al: Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction. J Nucl Cardiol 3:150-156, 1996

21.

21. Meluzin J , Cerny J , Frelich M , Stetka F , et al: Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. J Am Coll Cardiol 32:912-920, 1998.

22.

22. Hans F , Haehnel CJ , Picker W , Nekolla S , et al: Preoperative positron emission viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease [see comments]. J Am Coll Cardiol 30:1693-1700, 1997.

23.

23. Pierard LA , De Landsheere CM , Berthe C , Rigo P , et al: Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. JAm Coll Cardiol 15:1021-1031, 1990.

24.

24. Knudsen AS , Dampish AZ , Norgaard A , Gotzsche O , et al: Time course of myocardial viability after acute myocardial infarction: An echocardiographic study. Am Heart J 135:51-57, 1998.

25.

25. Barilla F , Gheorghiade M , Alan M , Khaja F , et al: Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 122:1522-1531, 1991.

26.

26. Schwarz ER , Schoendube FA , Kostin S , Schmiedtke N , et al: Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. J Am Coll Cardiol 31:1018-1026, 1998.

27.

27. Beanlands RS , Hendry PJ , Masters RG , deKemp RA , et al: Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 98:1151-1156, 1998.

28.

28. Van Campen CMC , Visser FC , Visser CA : Ejection fraction improvement by beta-blocker treatment in patients with heart failure: An analysis of studies published in the literature. J Cardiovasc Pharmacol 32(suppl 1):S31-S35, 1998.